|Bid||0.00 x 900|
|Ask||0.00 x 1100|
|Day's Range||192.30 - 194.38|
|52 Week Range||132.75 - 217.16|
|Beta (3Y Monthly)||1.35|
|PE Ratio (TTM)||61.65|
|Earnings Date||Oct 28, 2019 - Nov 1, 2019|
|Forward Dividend & Yield||1.28 (0.61%)|
|1y Target Est||219.17|
MINNEAPOLIS , Aug. 20, 2019 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced the release of the Maurice Empower ® Control Kit for the ProteinSimple™-branded Maurice platform. This ...
MINNEAPOLIS , Aug. 15, 2019 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ:TECH) today announced that Chuck Kummeth , President and Chief Executive Officer, will present at the Baird 2019 Global Healthcare ...
MINNEAPOLIS and SOUTHPORT, N.C. , Aug. 13, 2019 /PRNewswire/ -- Bio-Techne Corporation and Cygnus Technologies, part of Maravai LifeSciences, announced today a strategic partnership for the quantification ...
Techne (TECH) delivered earnings and revenue surprises of -4.58% and -3.20%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?
MINNEAPOLIS , Aug. 6, 2019 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) announced that its Board of Directors has decided to pay a dividend of $0.32 per share for the quarter ended June 30, 2019 ...
MINNEAPOLIS , Aug. 6, 2019 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ:TECH) today reported its financial results for the fourth quarter ended June 30, 2019 . Fourth Quarter FY2019 Snapshot Fourth quarter ...
Within the Health Care Benefits segment, CVS Health (CVS) expects the government programs to go from strength to strength on the back of Medicare growth and major Medicaid wins.
GW Pharmaceuticals (GWPH) is witnessing a solid new patient recruitment for Epidolex and a huge number of physicians are recommending the same in their prescriptions.
This article is for investors who would like to improve their understanding of price to earnings ratios (P/E ratios...
MINNEAPOLIS, July 23, 2019 /PRNewswire/ -- Uman Diagnostics, now part of Quanterix, and Bio-Techne announced today a strategic License and Supply Agreement for the antibodies used in the quantification of neurofilament light (Nf-L) on the ProteinSimple™-branded Ella™ immunoassay platform. Under the terms of the agreement, Uman Diagnostics will supply Nf-L antibodies to Bio-Techne for use in its proprietary Simple Plex™ immunoassays on Ella.
MINNEAPOLIS , July 18, 2019 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ:TECH) today announced that management will host a conference call on Tuesday, August 6, 2019 , at 8:00 a.m. CDT to review fourth ...
MINNEAPOLIS , July 17, 2019 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced the launch of a new 8-Plex cartridge format for the ProteinSimple™-branded Ella™ automated immunoassay ...
Expanding research tools for Spatial Genomics by combining molecular information with spatial context in one simple assay. MINNEAPOLIS , July 11, 2019 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ:TECH) ...
Techne (TECH) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
MINNEAPOLIS, July 9, 2019 /PRNewswire/ -- Bio-Techne Corporation (TECH) today announced that its President and CEO, Chuck Kummeth, was recently honored with the EY Entrepreneur Of The Year® 2019 Award in the Heartland. The EY awards program recognizes entrepreneurs and leaders of high-growth companies who are excelling in areas such as innovation, financial performance, and personal commitment to their businesses and communities, while also transforming the world. Mr. Kummeth was chosen by an independent panel of judges as one of a select few that are not only driving their companies' success, but are also transforming their industries by creating new solutions, innovations, and possibilities.